| |
 |
Robert C. Brunham Patents |
|
Inventor: Brunham; Robert C.
Address: Vancouver, CA
No. of patents: 10
Patents:
| Patent Number |
Title Of Patent |
Date Issued |
| 7229975 |
DNA immunization against chlamydia infection |
June 12, 2007 |
| Nucleic acid, including DNA, immunization is used to generate a protective immune response in a host, including humans, to a serine-threonine kinase (STK) of a strain of Chlamydia. A non-replicating vector, including a plasmid vector, contains a nucleotide sequence encoding a STK or a |
| 7220423 |
DNA immunization against Chlamydia infection |
May 22, 2007 |
| Nucleic acid, including DNA, for immunization to generate a protective immune response in a host, including humans, to a major outer membrane protein of a strain of Chlamydia, preferably contains a nucleotide sequence encoding a MOMP or a MOMP fragment that generates antibodies that |
| 7063853 |
DNA immunization against Chlamydia infection |
June 20, 2006 |
| Nucleic acid, including DNA, for immunization to generate a protective immune response in a host, including humans, to a major outer membrane protein of a strain of Chlamydia, preferably contains a nucleotide sequence encoding a fragment that generates antibodies that specifically re |
| 7026300 |
One step immunization procedure for inducing a Chlamydia specific immune response |
April 11, 2006 |
| A host is immunized against infection by a strain of Chlamydia by initial administration of an attenuated bacteria harbouring a nucleic acid encoding a Chlamydia protein followed by administration of a Chlamydia protein in ISCOMs. This procedure enables a high level of protection to |
| 6838085 |
DNA immunization against Chlamydia infection |
January 4, 2005 |
| Nucleic acid, including DNA, for immunization to generate a protective immune response in a host, including humans, to a major outer membrane protein of a strain of Chlamydia, preferably contains a nucleotide sequence encoding a MOMP or a MOMP fragment that generates antibodies that |
| 6696421 |
DNA immunization against chlamydia infection |
February 24, 2004 |
| Nucleic acid, including DNA, immunization to generate a protective immune response in a host, including humans, to a major outer membrane protein of a strain of Chlamydia, preferably contains a nucleotide sequence encoding a MOMP or a MOMP fragment that generates antibodies that specific |
| 6676949 |
Two-step immunization procedure against Chlamydia infection |
January 13, 2004 |
| A host is immunized against infection by a strain of Chlamydia by initial administration of an attenuated bacteria harbouring a nucleic acid encoding a Chlamydia protein followed by administration of a Chlamydia protein in ISCOMs. This procedure enables a high level of protection to be |
| 6632663 |
DNA immunization against chlamydia infection |
October 14, 2003 |
| Nucleic acid, including DNA, immunization is used to generate a protective immune response in a host, including humans, to a serine-threonine kinase (STK) of a strain of Chlamydia. A non-replicating vector, including a plasmid vector, contains a nucleotide sequence encoding a STK or a |
| 6344202 |
DNA immunization against chlaymdia infection |
February 5, 2002 |
| Nucleic acid, including DNA, for immunization to generate a protective immune response in a host, including humans, to a major outer membrane protein of a strain of Chlamydia, preferably contains a nucleotide sequence encoding a MOMP or a MOMP fragment that generates antibodies that |
| 6235290 |
DNA immunization against chlaymdia infection |
May 22, 2001 |
| Nucleic acid, including DNA, immunization to generate a protective immune response in a host, including humans, to a major outer membrane protein of a strain of Chlamydia, preferably contains a nucleotide sequence encoding a MOMP or a MOMP fragment that generates antibodies that specific |
|
|
|
